Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women : two weeks of confirmed presentations to an affiliated pair of New York City hospitals
© 2020 Elsevier Inc. All rights reserved..
Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019-positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019-associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease).
| Errataetall: |
CommentIn: Am J Obstet Gynecol MFM. 2020 Aug;2(3):100160. - PMID 32838265 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
American journal of obstetrics & gynecology MFM - 2(2020), 2 vom: 01. Mai, Seite 100118 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Breslin, Noelle [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 25.01.2021 Date Revised 01.07.2023 published: Print-Electronic CommentIn: Am J Obstet Gynecol MFM. 2020 Aug;2(3):100160. - PMID 32838265 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajogmf.2020.100118 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308778782 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308778782 | ||
| 003 | DE-627 | ||
| 005 | 20231225132455.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajogmf.2020.100118 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308778782 | ||
| 035 | |a (NLM)32292903 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Breslin, Noelle |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women |b two weeks of confirmed presentations to an affiliated pair of New York City hospitals |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.01.2021 | ||
| 500 | |a Date Revised 01.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Am J Obstet Gynecol MFM. 2020 Aug;2(3):100160. - PMID 32838265 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Elsevier Inc. All rights reserved. | ||
| 520 | |a Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019-positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019-associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a novel coronavirus | |
| 650 | 4 | |a pregnancy | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Azithromycin |2 NLM | |
| 650 | 7 | |a 83905-01-5 |2 NLM | |
| 700 | 1 | |a Baptiste, Caitlin |e verfasserin |4 aut | |
| 700 | 1 | |a Gyamfi-Bannerman, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Russell |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Bernstein, Kyra |e verfasserin |4 aut | |
| 700 | 1 | |a Ring, Laurence |e verfasserin |4 aut | |
| 700 | 1 | |a Landau, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Purisch, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Friedman, Alexander M |e verfasserin |4 aut | |
| 700 | 1 | |a Fuchs, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Sutton, Desmond |e verfasserin |4 aut | |
| 700 | 1 | |a Andrikopoulou, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Rupley, Devon |e verfasserin |4 aut | |
| 700 | 1 | |a Sheen, Jean-Ju |e verfasserin |4 aut | |
| 700 | 1 | |a Aubey, Janice |e verfasserin |4 aut | |
| 700 | 1 | |a Zork, Noelia |e verfasserin |4 aut | |
| 700 | 1 | |a Moroz, Leslie |e verfasserin |4 aut | |
| 700 | 1 | |a Mourad, Mirella |e verfasserin |4 aut | |
| 700 | 1 | |a Wapner, Ronald |e verfasserin |4 aut | |
| 700 | 1 | |a Simpson, Lynn L |e verfasserin |4 aut | |
| 700 | 1 | |a D'Alton, Mary E |e verfasserin |4 aut | |
| 700 | 1 | |a Goffman, Dena |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of obstetrics & gynecology MFM |d 2019 |g 2(2020), 2 vom: 01. Mai, Seite 100118 |w (DE-627)NLM297893440 |x 2589-9333 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:2 |g day:01 |g month:05 |g pages:100118 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajogmf.2020.100118 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 2 |b 01 |c 05 |h 100118 | ||